Latest filing published 23 Jan 2026 for Soleno Therapeutics INC.
Filings by Manher Joshi span 2 companies, the busiest being Atara Biotherapeutics, Inc. and Soleno Therapeutics Inc. Over a trading history stretching from 16 August 2023 to 21 January 2026, the count stands at 5 filings.
The open-market record consists of 3 sales worth €15k, with no purchase. Other entries cover 2 share grants.
Most recently, on 23 January 2026, the filings show a share grant in Soleno Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations